Rentschler Announces 3rd INDUSTRIAL CELL CULTURE TECHNOLOGY CONFERENCE on Processes for Virus-based Biologics
Virus-based biologics play an increasing role in the development of innovative gene, immuno and virotherapeutics. Novel…
Virus-based biologics play an increasing role in the development of innovative gene, immuno and virotherapeutics. Novel…
Rentschler, a leading CMO for the development and production of biopharmaceuticals, has hosted its second Laupheimer Zel…
Rentschler Biotechnologie GmbH is pleased to announce the second Laupheimer Zelltage , a biennial industrial cell cultur…
Rentschler Biotechnologie GmbH launched the first "Laupheimer Zelltage" with a symposium on "Cell Factories of the Futur…
Mit einem Symposium über 'Zellfabriken der Zukunft' hat Rentschler Biotechnologie GmbH die Laupheimer Zelltage ins Leben…